Agency Information Collection Activities: Proposed Collection; Comment Request, 24957-24959 [2012-10009]
Download as PDF
<![CDATA[
24957
Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices
TABLE 3—COST TO THE FEDERAL GOVERNMENT—Continued
Cost component
Total cost
Annualized
cost
Government Oversight .............................................................................................................................................
13,710
4,570
Total ..................................................................................................................................................................
499,877
166,626
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ healthcare
research and healthcare information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: April 19, 2012.
Carolyn M. Clancy,
Director.
Proposed Project
[FR Doc. 2012–10007 Filed 4–25–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘American Recovery and Reinvestment
Act ‘‘Developing a Registry of
Registries’’.’’ In accordance with the
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:51 Apr 25, 2012
Paperwork Reduction Act, 44 U.S.C.
3501–3521, AHRQ invites the public to
comment on this proposed information
collection.
This proposed information collection
was previously published in the Federal
Register on February 23, 2012 and
allowed 60 days for public comment. No
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
DATES: Comments on this notice must be
received by May 29, 2012.
ADDRESSES: Written comments should
be submitted to: AHRQ’s OMB Desk
Officer by fax at (202) 395–6974
(attention: AHRQ’s desk officer) or by
email at
OIRA_submission@omb.eop.gov
(attention: AHRQ’s desk officer).
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Jkt 226001
American Recovery and Reinvestment
Act ‘‘Developing a Registry of
Registries’’
The Food and Drug Administration
Modernization Act of 1997, Public Law
105–115, provided for the creation of a
Clinical Trials Data Bank, known as
ClinicalTrials.gov. Since its launch in
2000, the ClinicalTrials.gov system has
registered over 90,500 trials. The large
volume of studies currently listed in
ClinicalTrials.gov and the high usage
numbers suggest that the system has
been successful at improving access to
information about clinical studies.
However, while ClinicalTrials.gov
supports the listing of observational
studies, such listing is not required.
Patient registries are a distinct type of
observational study. Patient registries
may be designed for many purposes,
such as to observe the natural history of
disease, examine comparative
effectiveness, or fulfill post-approval
commitments. Patient registries have
specific characteristics that are not
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
currently captured on
ClinicalTrials.gov. To date, some
registry sponsors have attempted to
leverage the observational study model
to post patient registry-type records on
ClinicalTrials.gov. However,
stakeholders have noted that the system
does not fully meet their needs.
Patient registries have received
significant attention and funding in
recent years. Similar to controlled
interventional studies, patient registries
represent some burden to patients (e.g.,
time to complete patient reported
outcome measures, risk of loss of
privacy), who often participate
voluntarily in hopes of improving
knowledge about a disease or condition.
Patient registries also represent a
substantial investment of health
research resources. Despite these
factors, registration of patient registries
in ClinicalTrials.gov is not currently
required, presenting the potential for
duplication of efforts and insufficient
dissemination of findings that are not
published in the peer-reviewed
literature. To ensure that resources are
used in the most efficient manner,
registries need to be listed in a manner
similar to that of trials in
ClinicalTrials.gov.
By creating a central point of
collection for information about all
patient registries in the United States,
the Registry of Patient Registries (RoPR)
helps to further AHRQ’s goals by
making information regarding quality,
appropriateness, and effectiveness of
health services (and patient registries in
particular) more readily available and
centralized.
The primary goal of this project is to
engage stakeholders in the design and
development of a RoPR database system
that is compatible with
ClinicalTrials.gov and meets the
following objectives:
(1) Provides a searchable database of
patient registries in the United States (to
promote collaboration, reduce
redundancy, and improve
transparency);
(2) Facilitates the use of common data
fields and definitions in similar health
conditions (to improve opportunities for
sharing, comparing, and linkage);
(3) Provides a public repository of
searchable summary results (including
E:\FR\FM\26APN1.SGM
26APN1
24958
Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices
results from registries that have not yet
been published in the peer-reviewed
literature);
(4) Offers a search tool to locate
existing data that researchers can
request for use in new studies; and
serves as a recruitment tool for
researchers and patients interested in
participating in patient registries.
This study is being conducted by
AHRQ through its contractor, the
Outcome DEcIDE Center, pursuant to
the American Recovery and
Reinvestment Act, Public Law 111–5,
and pursuant to AHRQ’s statutory
authority to conduct and support
research and disseminate information
on health care and on systems for the
delivery of such care, including
activities with respect to the quality,
effectiveness, efficiency,
appropriateness and value of health care
services and with respect to database
development. 42 U.S.C. 299a(a)(1) and
(8).
Method of Collection
To achieve the goals of this project the
following data collections will be
implemented:
(1) Collect information from registry
holders, defining a patient registry
profile via a web-based interface, to
populate the RoPR database system.
The purpose of the RoPR is to create
a readily available public resource in
the model of ClinicalTrials.gov to share
information on existing patient
registries to promote collaboration,
reduce redundancy, and improve
transparency in registry research.
Patient registry research has become
more prevalent and, based on
stakeholder feedback, is not adequately
served by ClinicalTrials.gov at present.
The information being collected in the
RoPR record will be visible to the public
visiting the RoPR Web site and will be
available for public use in this capacity.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden for the respondents’
time to participate in the RoPR. Because
the RoPR is a voluntary system available
to any entity conducting a patient
registry, it is not possible to determine
the number of potential respondents.
We do know that over 3,800 newly
registered records designated as
‘‘observational studies’’ were entered
into ClinicalTrials.gov in 2010. Only a
subset of this number (which we will
estimate at a maximum of 40%) would
qualify as patient registries and would
likely be registered in the RoPR.
Therefore, we use 1,520 (3,800*0.40) in
Exhibits 1 and 2 below as a very rough,
but high, estimation of the potential
number of respondents who will enter
registries into the RoPR annually. The
actual number of respondents will
depend on a variety of factors and could
vary widely. It should be remembered
that mandates could evolve making
registration in the RoPR mandatory. Our
estimates therefore attempt to factor an
upper threshold for volume.
Each respondent will enter a new
RoPR record only once and is estimated
to take 45 minutes. An estimated 50%
(760 records) of RoPR records will be
updated once a year and will take about
15 minutes. This estimate is based on a
query of ClinicalTrials.gov which
showed that about 50% of observational
studies registered in ClinicalTrials.gov
had been updated in the past year. The
total respondent burden is estimated to
be 1,330 hours annually.
Exhibit 2 shows the estimated cost
burden associated with the respondent’s
time to participate in the RoPR. The
total cost burden is estimated to be
$45,579 annually.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Hours per
response
Total burden
hours
New RoPR Record ..........................................................................................
Review/update RoPR Record ..........................................................................
1,520
760
1
1
45/60
15/60
1,140
190
Total ..........................................................................................................
2,280
na
na
1,330
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
espondents
Form Name
Total burden
hours
Average
hourly rate +
Total cost
burden
New RoPR Record ..........................................................................................
Review/update RoPR Record ..........................................................................
1,520
760
1,140
190
$34.27
34.27
$39,068
6,511
Total ..........................................................................................................
2,280
1,330
na
$45,579
+ Based upon the mean average wage for Healthcare Practitioners and Technical Occupations, May 2010 National Occupational Employment
and Wage Estimates, U.S. Department of Labor, Bureau of Labor Statistics. Available at: https://www.bls.gov/oes/current/oes_nat.htm#29–0000.
Estimated Annual Costs to the Federal
Government
tkelley on DSK3SPTVN1PROD with NOTICES
Exhibit 3 shows the estimated total
and annualized cost to the government
to create and maintain the RoPR for 3
years. The total cost is estimated to be
$3,184,333.
EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST
Cost component
Total cost
Project Development ...............................................................................................................................................
Project Management ................................................................................................................................................
Overhead .................................................................................................................................................................
VerDate Mar<15>2010
17:51 Apr 25, 2012
Jkt 226001
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
E:\FR\FM\26APN1.SGM
26APN1
$2,318,509
409,149
456,675
Annualized
cost
$772,836
136,383
152,225
24959
Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices
EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST—Continued
Cost component
Total cost
Total ..................................................................................................................................................................
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ healthcare
research and healthcare information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: April 19, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–10009 Filed 4–25–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Scientific Information Request on
Local Therapies for Unresectable
Primary Hepatocellular Carcinoma
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for scientific
information submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
manufacturers of local, minimally
invasive, medical devices for
unresectable primary hepatocellular
carcinoma (e.g., ablation, radiotherapy,
or embolization devices). Scientific
information is being solicited to inform
our Comparative Effectiveness Review
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:51 Apr 25, 2012
Jkt 226001
of Local Therapies for Unresectable
Primary Hepatocellular Carcinoma,
which is currently being conducted by
the Evidence-based Practice Centers for
the AHRQ Effective Health Care
Program. Access to published and
unpublished pertinent scientific
information on this device will improve
the quality of this comparative
effectiveness review. AHRQ is
requesting this scientific information
and conducting this comparative
effectiveness review pursuant to Section
1013 of the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, Public Law 108–173.
DATES: Submission Deadline on or
before May 29, 2012.
ADDRESSES:
Online submissions: https://effective
healthcare.AHRQ.gov/index.cfm/submit
scientific-information-packets/. Please
select the study for which you are
submitting information from the list of
current studies and complete the form
to upload your documents.
Email submissions: ehcsrc@ohsu.edu
(please do not send zipped files—they
are automatically deleted for security
reasons).
Print submissions: Robin Paynter,
Oregon Health and Science University,
Oregon Evidence-based Practice Center,
3181 SW Sam Jackson Park Road, Mail
Code: BICC, Portland, OR 97239–3098.
FOR FURTHER INFORMATION CONTACT:
Robin Paynter, Research Librarian,
Telephone: 503–494–0147 or Email:
ehcsrc@ohsu.edu.
SUPPLEMENTARY INFORMATION:
In accordance with Section 1013 of
the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, Public Law 108–173, the Agency
for Healthcare Research and Quality has
commissioned the Effective Health Care
(EHC) Program Evidence-based Practice
Centers to complete a comparative
effectiveness review of the evidence for
local therapies for unresectable primary
hepatocellular carcinoma.
The EHC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by systematically requesting
information (e.g., details of studies
conducted) from medical device
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
3,184,333
Annualized
cost
1,061,444
industry stakeholders through public
information requests, including via the
Federal Register and direct postal and/
or online solicitations. We are looking
for studies that report on local therapies
for unresectable primary hepatocellular
carcinoma, including those that describe
adverse events, as specified in the key
questions detailed below. The entire
research protocol, including the key
questions, is also available online at:
https://www.effective
healthcare.AHRQ.gov/index.cfm/
search-for-quides-reviews-and-reports/
?productid=1012&pageaction=display
product#5056.
This notice is a request for industry
stakeholders to submit the following:
• A current product label, if
applicable (preferably an electronic PDF
file).
• Information identifying published
randomized controlled trials and
observational studies relevant to the
clinical outcomes. Please provide both a
list of citations and reprints if possible.
• Information identifying
unpublished randomized controlled
trials and observational studies relevant
to the clinical outcomes. If possible,
please provide a summary that includes
the following elements: study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to withdrawn/follow-up/
analyzed, and effectiveness/efficacy and
safety results.
• Registered ClinicalTrials.gov
studies. Please provide a list including
the ClinicalTrials.gov identifier,
condition, and intervention.
Your contribution is very beneficial to
this program. AHRQ is not requesting
and will not consider marketing
material, health economics information,
or information on other indications.
This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter. In addition to your scientific
information please submit an index
document outlining the relevant
information in each file along with a
statement regarding whether or not the
submission comprises all of the
complete information available.
E:\FR\FM\26APN1.SGM
26APN1
]]>Agencies
[Federal Register Volume 77, Number 81 (Thursday, April 26, 2012)]
[Notices]
[Pages 24957-24959]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-10009]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``American Recovery and Reinvestment Act ``Developing a
Registry of Registries''.'' In accordance with the Paperwork Reduction
Act, 44 U.S.C. 3501-3521, AHRQ invites the public to comment on this
proposed information collection.
This proposed information collection was previously published in
the Federal Register on February 23, 2012 and allowed 60 days for
public comment. No comments were received. The purpose of this notice
is to allow an additional 30 days for public comment.
DATES: Comments on this notice must be received by May 29, 2012.
ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk
Officer by fax at (202) 395-6974 (attention: AHRQ's desk officer) or by
email at OIRA_submission@omb.eop.gov (attention: AHRQ's desk officer).
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
American Recovery and Reinvestment Act ``Developing a Registry of
Registries''
The Food and Drug Administration Modernization Act of 1997, Public
Law 105-115, provided for the creation of a Clinical Trials Data Bank,
known as ClinicalTrials.gov. Since its launch in 2000, the
ClinicalTrials.gov system has registered over 90,500 trials. The large
volume of studies currently listed in ClinicalTrials.gov and the high
usage numbers suggest that the system has been successful at improving
access to information about clinical studies. However, while
ClinicalTrials.gov supports the listing of observational studies, such
listing is not required.
Patient registries are a distinct type of observational study.
Patient registries may be designed for many purposes, such as to
observe the natural history of disease, examine comparative
effectiveness, or fulfill post-approval commitments. Patient registries
have specific characteristics that are not currently captured on
ClinicalTrials.gov. To date, some registry sponsors have attempted to
leverage the observational study model to post patient registry-type
records on ClinicalTrials.gov. However, stakeholders have noted that
the system does not fully meet their needs.
Patient registries have received significant attention and funding
in recent years. Similar to controlled interventional studies, patient
registries represent some burden to patients (e.g., time to complete
patient reported outcome measures, risk of loss of privacy), who often
participate voluntarily in hopes of improving knowledge about a disease
or condition. Patient registries also represent a substantial
investment of health research resources. Despite these factors,
registration of patient registries in ClinicalTrials.gov is not
currently required, presenting the potential for duplication of efforts
and insufficient dissemination of findings that are not published in
the peer-reviewed literature. To ensure that resources are used in the
most efficient manner, registries need to be listed in a manner similar
to that of trials in ClinicalTrials.gov.
By creating a central point of collection for information about all
patient registries in the United States, the Registry of Patient
Registries (RoPR) helps to further AHRQ's goals by making information
regarding quality, appropriateness, and effectiveness of health
services (and patient registries in particular) more readily available
and centralized.
The primary goal of this project is to engage stakeholders in the
design and development of a RoPR database system that is compatible
with ClinicalTrials.gov and meets the following objectives:
(1) Provides a searchable database of patient registries in the
United States (to promote collaboration, reduce redundancy, and improve
transparency);
(2) Facilitates the use of common data fields and definitions in
similar health conditions (to improve opportunities for sharing,
comparing, and linkage);
(3) Provides a public repository of searchable summary results
(including
[[Page 24958]]
results from registries that have not yet been published in the peer-
reviewed literature);
(4) Offers a search tool to locate existing data that researchers
can request for use in new studies; and serves as a recruitment tool
for researchers and patients interested in participating in patient
registries.
This study is being conducted by AHRQ through its contractor, the
Outcome DEcIDE Center, pursuant to the American Recovery and
Reinvestment Act, Public Law 111-5, and pursuant to AHRQ's statutory
authority to conduct and support research and disseminate information
on health care and on systems for the delivery of such care, including
activities with respect to the quality, effectiveness, efficiency,
appropriateness and value of health care services and with respect to
database development. 42 U.S.C. 299a(a)(1) and (8).
Method of Collection
To achieve the goals of this project the following data collections
will be implemented:
(1) Collect information from registry holders, defining a patient
registry profile via a web-based interface, to populate the RoPR
database system.
The purpose of the RoPR is to create a readily available public
resource in the model of ClinicalTrials.gov to share information on
existing patient registries to promote collaboration, reduce
redundancy, and improve transparency in registry research. Patient
registry research has become more prevalent and, based on stakeholder
feedback, is not adequately served by ClinicalTrials.gov at present.
The information being collected in the RoPR record will be visible to
the public visiting the RoPR Web site and will be available for public
use in this capacity.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated annualized burden for the
respondents' time to participate in the RoPR. Because the RoPR is a
voluntary system available to any entity conducting a patient registry,
it is not possible to determine the number of potential respondents. We
do know that over 3,800 newly registered records designated as
``observational studies'' were entered into ClinicalTrials.gov in 2010.
Only a subset of this number (which we will estimate at a maximum of
40%) would qualify as patient registries and would likely be registered
in the RoPR. Therefore, we use 1,520 (3,800*0.40) in Exhibits 1 and 2
below as a very rough, but high, estimation of the potential number of
respondents who will enter registries into the RoPR annually. The
actual number of respondents will depend on a variety of factors and
could vary widely. It should be remembered that mandates could evolve
making registration in the RoPR mandatory. Our estimates therefore
attempt to factor an upper threshold for volume.
Each respondent will enter a new RoPR record only once and is
estimated to take 45 minutes. An estimated 50% (760 records) of RoPR
records will be updated once a year and will take about 15 minutes.
This estimate is based on a query of ClinicalTrials.gov which showed
that about 50% of observational studies registered in
ClinicalTrials.gov had been updated in the past year. The total
respondent burden is estimated to be 1,330 hours annually.
Exhibit 2 shows the estimated cost burden associated with the
respondent's time to participate in the RoPR. The total cost burden is
estimated to be $45,579 annually.
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Form name Number of responses per Hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
New RoPR Record................................. 1,520 1 45/60 1,140
Review/update RoPR Record....................... 760 1 15/60 190
---------------------------------------------------------------
Total....................................... 2,280 na na 1,330
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Number of Total burden Average Total cost
Form Name respondents hours hourly rate + burden
----------------------------------------------------------------------------------------------------------------
New RoPR Record................................. 1,520 1,140 $34.27 $39,068
Review/update RoPR Record....................... 760 190 34.27 6,511
---------------------------------------------------------------
Total....................................... 2,280 1,330 na $45,579
----------------------------------------------------------------------------------------------------------------
+ Based upon the mean average wage for Healthcare Practitioners and Technical Occupations, May 2010 National
Occupational Employment and Wage Estimates, U.S. Department of Labor, Bureau of Labor Statistics. Available
at: https://www.bls.gov/oes/current/oes_nat.htm#29-0000.
Estimated Annual Costs to the Federal Government
Exhibit 3 shows the estimated total and annualized cost to the
government to create and maintain the RoPR for 3 years. The total cost
is estimated to be $3,184,333.
Exhibit 3--Estimated Total and Annualized Cost
------------------------------------------------------------------------
Annualized
Cost component Total cost cost
------------------------------------------------------------------------
Project Development..................... $2,318,509 $772,836
Project Management...................... 409,149 136,383
Overhead................................ 456,675 152,225
-------------------------------
[[Page 24959]]
Total............................... 3,184,333 1,061,444
------------------------------------------------------------------------
Request for Comments
In accordance with the Paperwork Reduction Act, comments on AHRQ's
information collection are requested with regard to any of the
following: (a) Whether the proposed collection of information is
necessary for the proper performance of AHRQ healthcare research and
healthcare information dissemination functions, including whether the
information will have practical utility; (b) the accuracy of AHRQ's
estimate of burden (including hours and costs) of the proposed
collection(s) of information; (c) ways to enhance the quality, utility,
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information upon the
respondents, including the use of automated collection techniques or
other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: April 19, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-10009 Filed 4-25-12; 8:45 am]
BILLING CODE 4160-90-M
